DNB
58
2
DG
40
-2
MTCH
53
2
LB
69
59
PX
73
7
CLX
55
4
NTRS
64
15
BLK
69
5
VNO
52
3
AEE
68
5
MAC
47
4
O
35
2
NEM
50
2
GLW
49
3
COST
44
-3
SPG
41
3
PPL
57
-2
WHR
57
-5
CF
57
-2
FDX
48
-2
DNB
58
2
DG
40
-2
MTCH
53
2
LB
69
59
PX
73
7
CLX
55
4
NTRS
64
15
BLK
69
5
VNO
52
3
AEE
68
5
MAC
47
4
O
35
2
NEM
50
2
GLW
49
3
COST
44
-3
SPG
41
3
PPL
57
-2
WHR
57
-5
CF
57
-2
FDX
48
-2
Financhill
Back

Capricor Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27

CAPR
Capricor Therapeutics

Last Price:
$7.16
Seasonality Move:
38.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Capricor Therapeutics Stock Forecast

  • Over the next 52 weeks, Capricor Therapeutics has on average historically risen by 4% based on the past 17 years of stock performance.
  • Capricor Therapeutics has risen higher in 9 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.94%
  • Is Capricor Therapeutics Stock Undervalued?
    The current Capricor Therapeutics [CAPR] share price is $7.24. The Score for CAPR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • CAPR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Capricor Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Capricor Therapeutics has on average historically risen by 4% based on the past 17 years of stock performance.

Capricor Therapeutics Stock Rating

Sell
27
Capricor Therapeutics (CAPR) is a Sell

Is Capricor Therapeutics overpriced?

  • Capricor Therapeutics has risen higher in 9 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.94%

Capricor Therapeutics Stock Price History

Is CAPR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAPR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
capricor.com

52-Week Data

52-Week High:
23.40
52-Week Low:
3.52

Prediction Charts

Market Cap:
330.9M
Price in USD:
7.24
Volume:
2.1M
Beta:
1.16

Technical Analysis

SMA50:
10.12
SMA100:
11.17
SMA200:
13.63
52-Wk Change:
49.59%

Stock Predictions

  • Is Capricor Therapeutics stock public?
    Yes, Capricor Therapeutics is a publicly traded company.
  • What is the Capricor Therapeutics stock quote today?
    The Capricor Therapeutics stock price is 7.24 USD today.
  • How to buy Capricor Therapeutics stock online?
    You can buy Capricor Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 10.33 10.18 10.50 9.80
Jun-27 10.25 11.17 11.58 9.99
Jun-30 11.18 9.91 11.19 9.88
Jul-1 9.69 9.70 10.02 9.47
Jul-2 9.67 10.02 10.10 9.45
Jul-3 10.14 10.25 10.56 10.12
Jul-7 9.90 9.90 10.11 9.65
Jul-8 9.98 10.17 10.30 9.87
Jul-9 10.46 11.42 11.88 10.34
Jul-10 11.45 11.40 11.54 10.62
Jul-11 7.00 7.64 8.68 6.74
Jul-14 7.39 7.39 7.49 6.85
Jul-15 7.38 7.18 7.46 6.95
Jul-16 7.19 7.24 7.44 6.83

Capricor Therapeutics Earnings

Capricor Therapeutics Earnings Report: Per Share Capricor Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Capricor Therapeutics Forecast Revenue Growth

Capricor Therapeutics Stock Analysis: Historical quarterly revenues per share for Capricor Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.83 per share, and an increase next year of $2.60 per share.

* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.